Production (Stage)
Hydreight Technologies Inc.
NURS.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.02% | 10.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.02% | 10.75% | |||
| Cost of Revenue | -13.13% | 18.21% | |||
| Gross Profit | -12.81% | -1.39% | |||
| SG&A Expenses | 6.88% | -0.29% | |||
| Depreciation & Amortization | 30.14% | 91.67% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.37% | 11.68% | |||
| Operating Income | -122.93% | -241.67% | |||
| Income Before Tax | 122.31% | -232.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 122.31% | -232.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 122.31% | -232.83% | |||
| EBIT | -122.93% | -241.67% | |||
| EBITDA | -615.38% | -208.33% | |||
| EPS Basic | 123.53% | -240.00% | |||
| Normalized Basic EPS | 120.00% | -233.33% | |||
| EPS Diluted | 123.53% | -240.00% | |||
| Normalized Diluted EPS | 120.00% | -233.33% | |||
| Average Basic Shares Outstanding | 1.77% | 3.40% | |||
| Average Diluted Shares Outstanding | 1.77% | 3.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||